Other Species / Isoforms
  Ron (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S216-p
AASFSPRsVSIRRLK
0 2
Ron (human) AASFSPRsVSIRRLk S215-p
Ron iso2 (human) AASFSPRSVSIRRLK S215
Ron (mouse) AASFSPRsVSIRRLK S216-p
K223
sVSIRRLKSDTSGFQ
0 2
Ron (human) sVSIRRLkADAsGFA K222-ub
Ron iso2 (human) SVSIRRLKADASGFA K222
Ron (mouse) sVSIRRLKSDTSGFQ K223
S227
RRLKSDTSGFQPGFP
0 1
Ron (human) RRLkADAsGFAPGFV S226-p
Ron iso2 (human) RRLKADASGFAPGFV S226
Ron (mouse) RRLKSDTSGFQPGFP S227
S237
QPGFPSLSVLPKYLA
0 1
Ron (human) APGFVALsVLPKHLV S236-p
Ron iso2 (human) APGFVALSVLPKHLV S236
Ron (mouse) QPGFPSLSVLPKYLA S237
N460-ng
LHVTRLGnVTVAHMG
0 1
Ron (human) LYVTRLDNVTVAHMG N458
Ron iso2 (human) LYVTRLDNVTVAHMG N458
Ron (mouse) LHVTRLGnVTVAHMG N460-ng
N722-ng
TSRAVLVnGTQCRLE
0 1
Ron (human) TSRAVLVNGTECLLA N720
Ron iso2 (human) TSRAVLVNGTECLLA N720
Ron (mouse) TSRAVLVnGTQCRLE N722-ng
-
gap
0 1
Ron (human) ATPLPILySGSDyRS Y1012-p
Ron iso2 (human) ATPLPILYSGSDYRS Y963
Ron (mouse) gap -
-
gap
0 8
Ron (human) ILySGSDyRSGLALP Y1017-p
Ron iso2 (human) ILYSGSDYRSGLALP Y968
Ron (mouse) gap -
S1033-p
VPLLRTEsIRLQDLD
0 5
Ron (human) VPLLRKEsIQLRDLD S1056-p
Ron iso2 (human) VPLLRKESIQLRDLD S1007
Ron (mouse) VPLLRTEsIRLQDLD S1033-p
K1048
RMLLAEVKDVLIPHE
0 1
Ron (human) SALLAEVkDVLIPHE K1071-ub
Ron iso2 (human) SALLAEVKDVLIPHE K1022
Ron (mouse) RMLLAEVKDVLIPHE K1048
Y1078
GVVYHGEYTDGAQNQ
0 5
Ron (human) GVVYHGEyIDQAQNR Y1101-p
Ron iso2 (human) GVVYHGEYIDQAQNR Y1052
Ron (mouse) GVVYHGEYTDGAQNQ Y1078
T1158
RSPQRNPTVKDLVSF
0 1
Ron (human) RSPQRNPtVKDLISF T1181-p
Ron iso2 (human) RSPQRNPTVKDLISF T1132
Ron (mouse) RSPQRNPTVKDLVSF T1158
Y1175-p
QVACGMEyLAEQKFV
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
Putative in vivo kinases:
  • Ron (mouse)
Ron (human) QVARGMEyLAEQKFV Y1198-p
Ron iso2 (human) QVARGMEYLAEQKFV Y1149
Ron (mouse) QVACGMEyLAEQKFV Y1175-p
Y1215-p
RGVLDKEyySVRQHR
Upstream
8 185
Regulatory protein:
  • HGFL (mouse)
Ron (human) RDILDREyysVQQHR Y1238-p
Ron iso2 (human) RDILDREYYSVQQHR Y1189
Ron (mouse) RGVLDKEyySVRQHR Y1215-p
Y1216-p
GVLDKEyySVRQHRH
Upstream
8 124
Regulatory protein:
  • HGFL (mouse)
Ron (human) DILDREyysVQQHRH Y1239-p
Ron iso2 (human) DILDREYYSVQQHRH Y1190
Ron (mouse) GVLDKEyySVRQHRH Y1216-p
S1217
VLDKEyySVRQHRHA
0 6
Ron (human) ILDREyysVQQHRHA S1240-p
Ron iso2 (human) ILDREYYSVQQHRHA S1191
Ron (mouse) VLDKEyySVRQHRHA S1217
Y1265-p
LTRGAPPyPHIDPFD
Upstream
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, induced
Putative in vivo kinases:
  • Ron (mouse)
Ron (human) LTRGAPPYRHIDPFD Y1288
Ron iso2 (human) LTRGAPPYRHIDPFD Y1239
Ron (mouse) LTRGAPPyPHIDPFD Y1265-p
Y1294-p
EYCPDSLyHVMLRCW
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
Putative in vivo kinases:
  • Ron (mouse)
Ron (human) EYCPDSLyQVMQQCW Y1317-p
Ron iso2 (human) EYCPDSLYQVMQQCW Y1268
Ron (mouse) EYCPDSLyHVMLRCW Y1294-p
Y1330-p
ASLLGDHyVQLTAAy
Upstream
Downstream
5 0
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • apoptosis, induced
  • cell growth, altered
Treatment
  • MSP
Ron (human) SALLGDHyVQLPATy Y1353-p
Ron iso2 (human) SALLGDHYVQLPATY Y1304
Ron (mouse) ASLLGDHyVQLTAAy Y1330-p
Y1337-p
yVQLTAAyVNVGPRA
Upstream
Downstream
5 0
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • apoptosis, induced
  • cell growth, altered
Treatment
  • MSP
Ron (human) yVQLPATyMNLGPST Y1360-p
Ron iso2 (human) YVQLPATYMNLGPST Y1311
Ron (mouse) yVQLTAAyVNVGPRA Y1337-p
S1372
TSKPRPLSEPPLPT_
2 24
Ron (human) VRRPRPLsEPPRPT_ S1394-p
Ron iso2 (human) VRRPRPLSEPPRPT_ S1345
Ron (mouse) TSKPRPLSEPPLPT_ S1372